Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1637

1.

Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria.

Kaddu S, Zenahlik P, Beham-Schmid C, Kerl H, Cerroni L.

J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):966-78.

PMID:
10365929
2.

CD56+ blastic transformation of chronic myeloid leukemia involving the skin.

Kaddu S, Beham-Schmid C, Zenahlik P, Kerl H, Cerroni L.

J Cutan Pathol. 1999 Nov;26(10):497-503.

PMID:
10599940
3.

Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia: a clinicopathologic and prognostic study of 42 patients.

Cerroni L, Zenahlik P, Höfler G, Kaddu S, Smolle J, Kerl H.

Am J Surg Pathol. 1996 Aug;20(8):1000-10.

PMID:
8712287
6.

Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.

Cerroni L, Signoretti S, Höfler G, Annessi G, Pütz B, Lackinger E, Metze D, Giannetti A, Kerl H.

Am J Surg Pathol. 1997 Nov;21(11):1307-15.

PMID:
9351568
7.

Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.

Kaiserling E, Horny HP, Geerts ML, Schmid U.

Mod Pathol. 1994 Sep;7(7):771-9.

PMID:
7824512
8.

Specific skin manifestations in acute leukemia with monocytic differentiation. A morphologic and immunohistochemical study of 11 cases.

Sepp N, Radaszkiewicz T, Meijer CJ, Smolle J, Seewann H, Fritsch P, Kerl H.

Cancer. 1993 Jan 1;71(1):124-32.

9.

Cutaneous infiltrates of acute myelogenous leukemia simulating inflammatory dermatoses.

Martínez-Escanamé M, Zuriel D, Tee SI, Fried I, Massone C, Cerroni L.

Am J Dermatopathol. 2013 Jun;35(4):419-24. doi: 10.1097/DAD.0b013e31826ffe6f.

PMID:
23221486
10.

CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.

Cascavilla N, Musto P, D'Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M.

Haematologica. 1998 May;83(5):392-7.

11.

CD117/CD34 expression in leukemic blasts.

Wells SJ, Bray RA, Stempora LL, Farhi DC.

Am J Clin Pathol. 1996 Aug;106(2):192-5.

PMID:
8712172
12.
13.

Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.

DiGiuseppe JA, Louie DC, Williams JE, Miller DT, Griffin CA, Mann RB, Borowitz MJ.

Am J Surg Pathol. 1997 Oct;21(10):1223-30.

PMID:
9331296
14.

Value of immunohistochemistry in the diagnosis of leukemia cutis: study of 54 cases using paraffin-section markers.

Ratnam KV, Su WP, Ziesmer SC, Li CY.

J Cutan Pathol. 1992 Jun;19(3):193-200.

PMID:
1383298
15.

Prognostic evaluation of specific cutaneous infiltrates in B-chronic lymphocytic leukemia.

Kaddu S, Smolle J, Cerroni L, Kerl H.

J Cutan Pathol. 1996 Dec;23(6):487-94.

PMID:
9001978
17.

Cutaneous involvement in lymphoblastic lymphoma.

Chimenti S, Fink-Puches R, Peris K, Pescarmona E, Pütz B, Kerl H, Cerroni L.

J Cutan Pathol. 1999 Sep;26(8):379-85.

PMID:
10551409
18.

Granulocytic sarcoma of the female genital tract: a clinicopathologic study of 11 cases.

Oliva E, Ferry JA, Young RH, Prat J, Srigley JR, Scully RE.

Am J Surg Pathol. 1997 Oct;21(10):1156-65.

PMID:
9331287
19.

Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.

Orazi A, Chiu R, O'Malley DP, Czader M, Allen SL, An C, Vance GH.

Mod Pathol. 2006 Dec;19(12):1536-45. Epub 2006 Oct 13.

20.

Concurrent Sweet's syndrome and leukemia cutis in patients with myeloid disorders.

del Pozo J, Martínez W, Pazos JM, Yebra-Pimentel MT, García Silva J, Fonseca E.

Int J Dermatol. 2005 Aug;44(8):677-80.

PMID:
16101872

Supplemental Content

Support Center